/ALPS
ALPS Stock - Alps Group Inc
Healthcare|BiotechnologyNASDAQ
$0.95-4.99%
$0.05 (-4.99%) • Dec 19
59
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.19
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $1.05
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for ALPS
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.94 – $0.96
TARGET (TP)$1.09
STOP LOSS$0.87
RISK/REWARD1:1.7
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta-0.02
52W High$2.90
52W Low$0.56
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Revenue | $3.37M | $2.40M | $3.59M | N/A |
| Gross Profit | $1.30M | $598,930 | $1.98M | N/A |
| Gross Margin | 38.6% | 24.9% | 55.0% | N/A |
| Operating Income | $-2,480,893 | $-2,355,731 | $-535,452 | $-135,649 |
| Net Income | $-2,513,573 | $-2,304,026 | $-729,159 | $-119,631 |
| Net Margin | -74.6% | -95.9% | -20.3% | N/A |
| EPS | $-0.68 | $-0.38 | $0.01 | $-0.00 |
Company Overview
Alps Group Inc is an integrated biotechnology platform providing research and development, medical services, and wellness solutions focused on advanced therapies. The company aims to create a fair healthcare ecosystem with accessible predictive, preventive, and precision medicine.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
ALPSLoading earnings data...
Latest News
Loading news...
Frequently Asked Questions about ALPS
What is ALPS's current stock price?
Alps Group Inc (ALPS) is currently trading at $0.95 per share. The stock has moved -4.99% today.
What is the analyst price target for ALPS?
No analyst price targets are currently available for this stock.
What sector is Alps Group Inc in?
Alps Group Inc operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the NASDAQ exchange.
What is ALPS's market cap?
Alps Group Inc has a market capitalization of $0.16 billion, making it a small-cap company.
Does ALPS pay dividends?
No, Alps Group Inc does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorARGYF
Avanti Helium Corp.
$0.10
Mkt Cap: $0.0B
BNRG
Brenmiller Energy Ltd
$0.67
Mkt Cap: $0.0B
CHKR
Chesapeake Granite Wash Trust
$0.43
Mkt Cap: $0.0B
EDBL
Edible Garden AG Incorporated
$1.05
Mkt Cap: $0.0B
GIPR
Generation Income Properties, Inc.
$0.74
Mkt Cap: $0.0B
GRNT
Granite Ridge Resources, Inc
$4.64
Mkt Cap: $0.6B
HGTXU
Hugoton Royalty Trust
$0.32
Mkt Cap: $0.0B
INDO
Indonesia Energy Corporation Limited
$2.91
Mkt Cap: $0.0B
OKYO
OKYO Pharma Limited
$2.03
Mkt Cap: $0.1B
Explore stocks similar to ALPS for comparison